Concord Drugs Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 20.90 | 35.56 | 16.86 |
| Operating Expense | 18.66 | 34.13 | 15.97 |
| Net Profit | 1.11 | 0.52 | 0.22 |
| Net Profit Margin | 5.31% | 1.46% | 1.30% |
| Earning Per Share | 0.84 | 0.46 | 0.16 |
| EBIDTA | 2.25 | 1.42 | 0.89 |
| Effective Tax Rate | 19.64% | 14.69% | 7.87% |
Particulars
Jun 2026
Revenue20.90
Operating Expense18.66
Net Profit1.11
Net Profit Margin5.31
Earning Per Share0.84
EBIDTA2.25
Effective Tax Rate19.64
